Iron deficiency anaemia (IDA) is the most common cause of anaemia and is a problem worldwide, with an estimated 500 million people affected, occurring both in low-income countries such as sub-Saharan...
I'm sure you have all read the more outlandish and outright illogical arguments for not having the COVID-19 vaccine, and these don't really warrant touching upon in a healthcare journal, but there are...
Following new draft guidance from the National Institute for Health and Care Excellence (NICE), midostaurin (Rydapt, Novartis) has been recommended for the treatment of advanced systemic mastocytosis...
Day 1: After large-scale production of cortisone was enabled in the 1950s, more cortisol derivatives were discovered, such as #dexamethasone in 1957. Long acting and more potent, #dexamethasone has...
Recently published in the British Medical Journal, Blum et al's (2021) cluster randomised controlled trial looked at 110 clusters of inpatient wards within university-based hospitals across four...
On 20 June 2017 – the United Nations World Refugee Day – Abbas et al (2018) convened a workshop during the 4th International Conference on Prevention and Infection Control in Geneva. The authors note...
The primary focus of the research in NMP to date has been on its impact on patients, practitioners and organisations (Courtenay et al, 2018; Carey et al, 2020). Other studies have identified...
The new guideline for NICE (2021) recommends that patients presenting with new or ongoing symptoms 4 weeks or later after an initial COVID-19 infection should have the following investigations done; a...
The National Review of Asthma Deaths (NRAD) (Royal College of Physicians, 2014) investigated the clinical records of 195 adults and children who died of asthma between February 2012 and January 2013....
I don't know about you, but I find it difficult when reading news and updates these days not to see COVID-19 everywhere I look! But a few non-COVID things have caught my eye this month, and one...
Enzalutamide plus androgen deprivation therapy (ADT) is recommended by NICE, within its marketing authorisation, as an option for treating hormone-sensitive metastatic prostate cancer in adults.
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills